# US FDA commissioner nomination process

> Developing situation record from CLSTR: https://clstr.news/situations/us-fda-commissioner-nomination-process
> Updated: 2026-11-17T14:45:29.000Z. Sources: 38. Developments: 2.

The nomination of Dr. Heidi Overton to lead the Food and Drug Administration (FDA) has faced significant political scrutiny. Nominated by President Donald Trump, Overton encountered opposition from Republican Senator Bill Cassidy, pro-life activists regarding abortion pill safety, and vaccine skeptics.

As the Senate confirmation process continued, Congressional Republicans discussed Senator Roger Marshall as a potential alternative nominee. This consideration followed opposition to Overton from moderate Republicans and anti-abortion groups. Republican leadership faced time constraints to confirm a nominee before Democrats assumed the Senate majority in January.

The White House has officially withdrawn the nomination of Dr. Heidi Overton. The decision follows significant opposition from Senate Republicans and concerns regarding her ability to secure the necessary votes for confirmation. Senator Bill Cassidy, chair of the Senate Health, Education, Labor, and Pensions Committee, had expressed reservations about Overton’s scientific independence and her willingness to challenge the administration on issues such as childhood vaccine schedules. Additionally, Overton faced scrutiny from both sides of the aisle regarding her stance on reproductive rights, specifically concerning the medication abortion pill mifepristone.

Following the withdrawal, reports indicate Republicans are considering Senator Roger Marshall, a physician who recently lost his reelection bid in Kansas, as a potential replacement nominee for the agency. The withdrawal occurred one day before a scheduled vote by the Senate Health, Education, Labor, and Pensions Committee. Beyond concerns over vaccine schedules, Senator Cassidy also cited a lack of managerial experience. Furthermore, supporters of the “Make America Healthy Again” (MAHA) movement, led by Health Secretary Robert F. Kennedy Jr., expressed skepticism regarding her ability to challenge corporate interests. The FDA has remained without a permanent commissioner since the resignation of Dr. Marty Makary in May.

## Claims

- The White House withdrew Heidi Overton's nomination for FDA commissioner. (reported by 30 sources)
- Senator Bill Cassidy expressed reservations about Overton's nomination. (reported by 12 sources)
- Overton supported an executive order to reduce federally recommended childhood vaccinations. (reported by 10 sources)
- Senator Bill Cassidy expressed that he believed Overton would have had the votes to pass out of committee and the full Senate. (reported by 8 sources)
- The White House is considering Senator Roger Marshall as a replacement nominee for FDA commissioner. (reported by 7 sources)
- The FDA has been without a permanent commissioner since May 2026. (reported by 7 sources)
- Overton supported a plan to break up combination vaccines, including the measles, mumps, and rubella shot. (reported by 7 sources)

## Timeline

### 2026-11-17: White House withdraws FDA nominee Heidi Overton

The White House has pulled Dr. Heidi Overton’s nomination for FDA commissioner amid Senate opposition regarding vaccine policy, reproductive rights, and friction with the MAHA movement.

36 sources. https://clstr.news/cluster/roger-marshall-considered-as-potential-fda-nominee

### 2026-11-10: Senate panel to vote on FDA commissioner nominee Heidi Overton

The Senate health committee will vote on Dr. Heidi Overton’s nomination for FDA commissioner, amid skepticism from Republican Senator Bill Cassidy and pressure from various political activists.

2 sources. https://clstr.news/cluster/senate-panel-to-vote-on-fda-commissioner-nominee-heidi-overton

---
Cite as: US FDA commissioner nomination process. CLSTR, https://clstr.news/situations/us-fda-commissioner-nomination-process
